Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) (Parentheticals)

v3.7.0.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) (Parentheticals) - USD ($)
3 Months Ended 9 Months Ended
Jul. 31, 2017
Jul. 31, 2016
Jul. 31, 2017
Jul. 31, 2016
Research and Development Expense [Member]        
Non-cash Stock Option Compensation Expenses $ 64,705 $ 84,316 $ 213,333 $ 171,241
Selling and Marketing Expense [Member]        
Non-cash Stock Option Compensation Expenses $ 416,411 $ 156,125 $ 719,440 $ 398,949